| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |